We are live on ! Find out more
Royce & Associates

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$9.86B
AUM Growth
-$168M
Cap. Flow
-$326M
Cap. Flow %
-3.31%
Top 10 Hldgs %
9.48%
Holding
825
New
63
Increased
274
Reduced
363
Closed
64
Avg Time Held
4.5 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
JJSF icon
J&J Snack Foods
JJSF
+$29.7M
2
WDFC icon
WD-40
WDFC
+$28.7M
3
CBZ icon
CBIZ
CBZ
+$27.6M
4
EXPO icon
Exponent
EXPO
+$19.4M
5
ANDG icon
Andersen Group
ANDG
+$19.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.8%
2 Technology 18.79%
3 Financials 16.43%
4 Consumer Discretionary 12.93%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IPAR icon
26
Interparfums
IPAR
$3.77B
$58M 0.59%
683,201
+202,207
+42% +$17.8M
2013 Q2
50 quarters
ONTO icon
27
Onto Innovation
ONTO
$11.3B
$57.7M 0.59%
365,735
+58,259
+19% +$8.27M
2013 Q2
50 quarters
ASO icon
28
Academy Sports + Outdoors
ASO
$3.64B
$57.6M 0.58%
1,151,937
-177,410
-13% -$8.8M
2022 Q3
13 quarters
CIGI icon
29
Colliers International
CIGI
$4.69B
$56.3M 0.57%
383,228
+2,348
+0.6% +$353K
2019 Q2
26 quarters
NPO icon
30
Enpro
NPO
$5.93B
$55.4M 0.56%
258,577
+18,143
+8% +$4.01M
2020 Q2
22 quarters
HCKT icon
31
Hackett Group
HCKT
$290M
$51.9M 0.53%
2,642,287
+60,956
+2% +$1.16M
2013 Q2
50 quarters
KD icon
32
Kyndryl
KD
$2.93B
$50.9M 0.52%
1,917,036
+186,620
+11% +$5.06M
2022 Q3
13 quarters
VVV icon
33
Valvoline
VVV
$4.07B
$50.4M 0.51%
1,733,739
+431,687
+33% +$13.9M
2023 Q2
10 quarters
BKU icon
34
Bankunited
BKU
$2.99B
$48.5M 0.49%
1,089,238
-160,373
-13% -$6.64M
2020 Q2
22 quarters
MRX
35
Marex Group Limited Ordinary Shares
MRX
$5.24B
$48.4M 0.49%
1,260,709
-158,223
-11% -$5.38M
2024 Q2
6 quarters
AGI icon
36
Alamos Gold
AGI
$13.4B
$47.3M 0.48%
1,224,091
-50,000
-4% -$1.74M
2013 Q2
50 quarters
SSD icon
37
Simpson Manufacturing
SSD
$7.23B
$47M 0.48%
291,046
+30,418
+12% +$5.14M
2013 Q2
50 quarters
IMAX icon
38
IMAX
IMAX
$2.84B
$46.7M 0.47%
1,264,397
-61,310
-5% -$2.14M
2020 Q4
20 quarters
EXPO icon
39
Exponent
EXPO
$3.46B
$45.3M 0.46%
652,109
+276,889
+74% +$19.4M
2024 Q1
7 quarters
COHU icon
40
Cohu
COHU
$2.53B
$44.6M 0.45%
1,918,424
+7,927
+0.4% +$182K
2013 Q2
50 quarters
CPRX icon
41
DELISTED
Catalyst Pharmaceutical
CPRX
$44.6M 0.45%
1,910,767
-124,198
-6% -$2.77M
2019 Q4
24 quarters
CECO icon
42
Ceco Environmental
CECO
$3.51B
$44.3M 0.45%
740,687
-84,473
-10% -$4.52M
2023 Q1
11 quarters
HCSG icon
43
Healthcare Services Group
HCSG
$1.48B
$43.8M 0.44%
2,292,895
-572,102
-20% -$10.3M
2013 Q2
50 quarters
LAZ icon
44
Lazard
LAZ
$3.54B
$43.5M 0.44%
896,328
+51,191
+6% +$2.55M
2013 Q2
50 quarters
KBR icon
45
KBR
KBR
$4.64B
$43.4M 0.44%
1,080,201
+23,851
+2% +$1.02M
2013 Q2
50 quarters
RBA icon
46
RB Global
RBA
$16.2B
$43.3M 0.44%
420,705
-23,820
-5% -$2.42M
2013 Q2
50 quarters
KLIC icon
47
Kulicke & Soffa
KLIC
$4.27B
$42.9M 0.43%
941,022
-181,644
-16% -$7.67M
2013 Q2
50 quarters
APAM icon
48
Artisan Partners
APAM
$2.34B
$42M 0.43%
1,031,344
-62,498
-6% -$2.67M
2013 Q2
50 quarters
KFY icon
49
Korn Ferry
KFY
$4.12B
$42M 0.43%
635,858
-26,057
-4% -$1.75M
2013 Q2
50 quarters
MHO icon
50
M/I Homes
MHO
$3.19B
$41.8M 0.42%
326,606
+16,445
+5% +$2.17M
2021 Q4
16 quarters

Similar funds

Royce & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Royce & Associates held 825 positions worth $9.86B, down 1.7% from $10B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $326M in Q4 2025, closing 64 positions and reducing 363 holdings. Its most notable exit was Charles River Laboratories, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in J&J Snack Foods worth $29.6M.

  • Royce & Associates's largest Q4 2025 buy was J&J Snack Foods: 327,501 shares worth $29.6M.
  • Royce & Associates added most to WD-40 in Q4 2025, an estimated $28.7M increase.
  • Royce & Associates's biggest Q4 2025 reduction was Haemonetics, cutting an estimated $42.3M.
  • Royce & Associates fully exited Charles River Laboratories in Q4 2025, selling an estimated $13.2M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $9.86B portfolio in Q4 2025.
  • Royce & Associates opened 63 new positions and closed 64 in Q4 2025.
  • Royce & Associates's portfolio value fell 1.7% quarter-over-quarter to $9.86B.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.